Search

everythinglearnresearchcommunity

for

Search:↓

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Understanding how epigenetic regulation affects stem cells is key to cancer insights and new treatments.

Cancer survivors need better skin care to improve their quality of life.

The document concludes that while some organisms can regenerate body parts, mammals generally cannot, and cancer progression is complex, involving mutations rather than a strict stem cell hierarchy.

Cancer cells often have more copies of TERT and TERC genes, which helps them grow and could affect patient outcomes.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

Grape seed extract may safely and effectively help prevent lung cancer.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.

Dutasteride may help shrink prostate cancer tumors.

Dog skin with hair loss, when transplanted to mice, regrew hair, suggesting the hair loss cause is likely body-wide, not skin-specific.

The document concludes that identifying the specific cells where skin cancers begin is important for creating better prevention, detection, and treatment methods.

Targeting Keratin 17 may help overcome cancer therapy resistance.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

Male pattern baldness is linked to a higher risk of certain skin cancers, especially on the scalp.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

Genetic variations contribute to over 10% of recurrent early pregnancy loss cases.

Pancreatic cancer pain management is inadequate due to the disease's severity and limited effectiveness of treatments.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

Eating more omega-3 and less omega-6 fatty acids may lower the risk of developing prostate cancer.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.